AtaiBeckley (ATAI) Profit After Tax (2020 - 2026)
AtaiBeckley (ATAI) reported Profit After Tax of -$61.1 million for Q3 2025, down 132.44% on a YoY basis from $188.4 million in Q3 2024, and down 120.2% sequentially from -$27.7 million in Q2 2025.
AtaiBeckley (ATAI) Profit After Tax (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Profit After Tax data on file, last reported at -$61.1 million in Q3 2025.
- For the quarter ending Q3 2025, Profit After Tax fell 132.44% year-over-year to -$61.1 million; the trailing twelve-month figure through Sep 2025 stood at -$116.3 million (down 120.44% YoY), and the FY2024 full-year result was -$150.0 million, down 273.03% from the prior year.
- Profit After Tax eased to -$29.8 million in Q1 2026 per ATAI's latest filing, from -$26.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$960000.0 in Q4 2024 and bottomed at -$29.8 million in Q1 2026.
- The 3-year median for Profit After Tax is -$26.5 million (2025), against an average of -$19.1 million.
- Across the five-year window, Profit After Tax sank 1028.73% in 2022 and soared 221.48% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$960000.0 in 2024, then plunged by 2656.77% to -$26.5 million in 2025, then slipped by 12.61% to -$29.8 million in 2026.
- Per Business Quant, the three latest ATAI Profit After Tax figures stand at -$29.8 million (Q1 2026), -$26.5 million (Q1 2025), and -$960000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -61.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.80 Mn |
| Sep 30, 2025 | -61.10 Mn |
| Jun 30, 2025 | -27.75 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Dec 31, 2024 | -960,000.00 |
| Dec 31, 2024 | -960,000.00 |
| Sep 30, 2024 | -26.29 Mn |
| Jun 30, 2024 | -57.37 Mn |
| Mar 31, 2024 | -27.38 Mn |
| Dec 31, 2023 | 58.29 Mn |
| Sep 30, 2023 | 43.37 Mn |
| Jun 30, 2023 | -33.77 Mn |
| Mar 31, 2023 | -34.35 Mn |
| Dec 31, 2022 | -50.04 Mn |
| Sep 30, 2022 | -35.70 Mn |
| Jun 30, 2022 | -37.51 Mn |
| Mar 31, 2022 | -37.56 Mn |
| Dec 31, 2021 | -88.88 Mn |
| Sep 30, 2021 | -31.16 Mn |